Riboflavin Supplementation in Patients with Crohn’s Disease [the RISE-UP study]

BACKGROUND AND AIMS: Crohn’s disease [CD] is characterised by chronic intestinal inflammation and dysbiosis in the gut. Riboflavin [vitamin B(2)] has anti-inflammatory, antioxidant and microbiome-modulatory properties. Here, we analysed the effect of riboflavin on oxidative stress, markers of inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: von Martels, Julius Z H, Bourgonje, Arno R, Klaassen, Marjolein A Y, Alkhalifah, Hassan A A, Sadaghian Sadabad, Mehdi, Vich Vila, Arnau, Gacesa, Ranko, Gabriëls, Ruben Y, Steinert, Robert E, Jansen, Bernadien H, Bulthuis, Marian L C, van Dullemen, Hendrik M, Visschedijk, Marijn C, Festen, Eleonora A M, Weersma, Rinse K, de Vos, Paul, van Goor, Harry, Faber, Klaas Nico, Harmsen, Hermie J M, Dijkstra, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303596/
https://www.ncbi.nlm.nih.gov/pubmed/31873717
http://dx.doi.org/10.1093/ecco-jcc/jjz208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303596/
https://www.ncbi.nlm.nih.gov/pubmed/31873717
http://dx.doi.org/10.1093/ecco-jcc/jjz208

Ejemplares similares